The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

SMMT FINANCIAL STATEMENTS

Summit Therapeutics PLC — balance sheet, income statement and cash flow trends

SMMTSummit Therapeutics PLC

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-750 M-500 M-250 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-48.4 K $ · -Infinity%Operating Income-874.8 M $ · -Infinity%Pre-tax Income-856 M $ · -Infinity%Net Income to Owners-856.1 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-48.4 K $—
Operating Income-874.8 M $—
EBITDA-624.2 M $—
Net Income to Owners-856.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets752.2 M
  • Equity630 M $84%
  • Current Liabilities103.6 M $14%
  • Long-term Liabilities18.6 M $2%

Key Figures

YoY change
Total Assets752.2 M $+286.6%
Total Liabilities122.2 M $+136.7%
Total Equity630 M $+340.8%
Cash & ST Investments690.7 M $+289.5%
Total Debt20.4 M $+405.2%
Net Debt-399 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-500 M0-429.3 M $Operating-137.4 M $Investing919.1 M $Financing352.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow-429.3 M $—
Capital Expenditures1.3 M $+209.5%
Free Cash Flow-430.6 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SMMT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.